Norditropin and Insomnia - a phase IV clinical study of FDA data

Summary:

Insomnia is reported as a side effect among people who take Norditropin (somatropin recombinant), especially for people who are female, 10-19 old, have been taking the drug for < 1 month also take Synthroid, and have Hypopituitarism.

The phase IV clinical study analyzes which people have Insomnia when taking Norditropin. It is created by eHealthMe based on reports of 4,878 people who have side effects when taking Norditropin from the FDA, and is updated regularly.

What is Norditropin?

Norditropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 4,920 Norditropin users. Check the latest studies of Norditropin.

What is Insomnia?

Insomnia (sleeplessness) is found to be associated with 3,118 drugs and 5,169 conditions by eHealthMe. Check the latest studies of Insomnia.

On Apr, 28, 2026

4,878 people reported to have side effects when taking Norditropin.
Among them, 48 people (0.98%) have Insomnia.

Among these 48 people:

How long have people been on Norditropin when they have Insomnia? *

What is the gender of people who have Insomnia when taking Norditropin? *

female: 60 %
male: 40 %

What is the age of people who have Insomnia when taking Norditropin? *

What are other drugs people take besides Norditropin? *

What are other side effects people have besides Insomnia? *

Headache (pain in head): 8 people, 16.67%
Weight Decreased: 7 people, 14.58%
Fatigue (feeling of tiredness): 7 people, 14.58%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 10.42%
Hyperhidrosis (abnormally increased sweating): 5 people, 10.42%
Head Injury: 5 people, 10.42%
Hair Loss: 5 people, 10.42%
Drug Ineffective: 5 people, 10.42%
Peripheral Swelling: 4 people, 8.33%
Rashes (redness): 4 people, 8.33%

What are the existing conditions these people have? *

Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 10 people, 20.83%
Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 3 people, 6.25%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.25%
Sheehan Syndrome (severe bleeding during childbirth can result in tissue death in the pituitary gland. this causes the gland to lose its ability to work properly): 2 people, 4.17%
Addison's Disease (addison's disease, a hormonal disorder disease): 2 people, 4.17%
Menopausal Symptoms: 2 people, 4.17%
Gout (uric acid crystals building up in the body): 2 people, 4.17%
Localised Infection (infection at the single location): 2 people, 4.17%
Failure To Thrive (inadequate weight gain and physical growth in children): 2 people, 4.17%
High Blood Pressure: 2 people, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Norditropin and have Insomnia?

- Check whether Insomnia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Norditropin:

Norditropin (4,920 reports)

Insomnia treatments and more:

Insomnia (438,078 reports)

Browse all side effects of Norditropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Insomnia:

Insomnia (3,118 drugs)

Browse all the conditions that are associated with Insomnia:

Insomnia (5,169 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Norditropin) and Norditropin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.